DrStockPick.com Stock Report!
Friday August 14, 2009
King Pharmaceuticals Inc. (NYSE: KG) said Thursday the Food and Drug Administration approved its drug Embeda, a painkiller that is designed to be abuse-resistant. The FDA approval covers the use of Embeda for moderate to severe chronic pain. Embeda’s primary ingredient is morphine, but the pills contain a core of a second drug called naltrexone. If the pill is taken normally, it will release the morphine. However if it is crushed or chewed, the naltrexone is released, canceling out the high from the morphine.
Blockbuster Inc. (NYSE: BBI)’s second-quarter loss narrowed as the struggling video rental chain cut costs amid declines in revenue.
Elizabeth Arden, Inc. (NasdaqGS: RDEN) reported a narrower-than-expected fiscal fourth-quarter loss as the company booked fewer charges and margins improved, but forecast lower-than-expected profit for 2010.
Red Robin Gourmet Burgers Inc. (NasdaqGS: RRGB) reported a narrower-than-expected fiscal fourth-quarter loss as the company booked fewer charges and margins improved, but forecast lower-than-expected profit for 2010.
Las Vegas Sands Corp. (NYSE: LVS), the casino operator controlled by billionaire Sheldon Adelson, has received a much-needed boost after its bankers allowed it to spin off its Macao operations as they agreed to amend a $3.3bn credit facility.
Source: E-Gate System from Alphatrade.com
No comments:
Post a Comment